-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PTbnef6hOv+OHzb1Jxzw93ey4fW16qjAVkuppLP1j4/aYJ9KSCus5lns98LPzTvv zb+yqs4I/Q0PBXXt1eMVKQ== 0000000000-08-062421.txt : 20090202 0000000000-08-062421.hdr.sgml : 20090202 20081218144050 ACCESSION NUMBER: 0000000000-08-062421 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20081218 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 PUBLIC REFERENCE ACCESSION NUMBER: 0001047469-08-002933 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH@/#PO3&EN96%R:7IE9"`Q+TP@-S0T M,R]/(#@O12`S,S`R+TX@,2]4(#(,[P$"#``240'\`T*96YD7!E+U!A9V4^/@UE;F1O8FH-.2`P(&]B:CP\+T9O;G0\/"]45#(@,3`@,"!2 M+U14-"`Q,B`P(%(^/B]0H$E^&OK5U MTFYVLOT(;6>GTP<%R[&V&#("DLF_WRL)+!SSTH>UQR`)Z^C<<\^]O'I_R^&^ M6[TM5Z_*,@(.Y6[%(V#XQ5O!8,UR6F10'E8,[O%75N;RM"(0E/_B,.24IU!N MQH7RC]\;,,H86QO48$ M$T\P&:-NZ\&8*B)W2"\3]T;$_.AXS M)E^C(X(P2ME,)RT>K"16C2##7%9T68W(JS$&8\"BE&,P5ZT^`&?A7[!K-?1[ M"?](H>&RVI M5;L=C[D>&@DQFUM\4$ZS[(P1 M0HF[%O>;?-E8.F<(TSAM^LS`GM"T+COAB'3"D7OC\M&X.RS7F`P!QZM&`VC# M$=L.)^XJL9(X:?H.1(\&41V6=$J@5^-CNMCOIH87T75JEGTOO@U0$N-JA8/$ MA-*8%48J,\]Q+J>!M@,[3TW+JJ<=SV['A;N=$CA_#4T<_.O`/(B2%^E[V4[( M=2MK^"3T+],BC3/G6R90=OJF>6,H11C=,9KCH'5L!W<;@^ZGD%ZJ<3_%AK>4 MO+6PDR!B@GRIW'ZVB9%W;M.X>#S@*.?.#A;ENRQ7_PDP`.W3VDX*#0IE;F1S M=')E86T-96YD;V)J#3$R(#`@;V)J/#PO4W5B='EP92]47!E+T9O;G0^/@UE;F1O8FH-,3,@,"!O8FH\ M/"]3=&5M5B`X,B]&;VYT3F%M92]4:6UE2A4:6UE'1'4W1A=&4O4T$@9F%LFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB,RXQ+3&UL;G,Z>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O M(CX*("`@("`@("`@/'AA<#I#&%P.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&%P.DUO M9&EF>41A=&4^,C`P."TQ,BTQ.%0Q-#HS.3HQ-RTP-3HP,#PO>&%P.DUO9&EF M>41A=&4^"B`@("`@("`@(#QX87`Z0W)E871E1&%T93XR,#`X+3$R+3$X5#$T M.C,Y.C$W+3`U.C`P/"]X87`Z0W)E871E1&%T93X*("`@("`@/"]R9&8Z1&5S M8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@&UL.FQA;F<] M(G@M9&5F875L="(^36EC&%P34TZ26YS=&%N8V5)1#YU=6ED.F$W8C%C-F5B+3&%P34TZ26YS=&%N8V5)1#X*("`@("`@/"]R M9&8Z1&5S8W)I<'1I;VX^"B`@(#PO')E9@T*,3$V#0HE)45/1@T* ` end -----END PRIVACY-ENHANCED MESSAGE-----